Published in Int Orthop on October 08, 2013
Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection. J Virol (2014) 0.86
Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis. Int Orthop (2014) 0.82
Curcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways. Mol Med Rep (2016) 0.78
Increased chemotaxis and activity of circulatory myeloid progenitor cells may contribute to enhanced osteoclastogenesis and bone loss in the C57BL/6 mouse model of collagen-induced arthritis. Clin Exp Immunol (2016) 0.75
Sympathetic Neurotransmitters Modulate Osteoclastogenesis and Osteoclast Activity in the Context of Collagen-Induced Arthritis. PLoS One (2015) 0.75
Effect of Vitamin D on Peripheral Blood Mononuclear Cells from Patients with Psoriasis Vulgaris and Psoriatic Arthritis. PLoS One (2016) 0.75
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J (1991) 8.31
Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest (2003) 3.14
Osteoimmunology: interactions of the bone and immune system. Endocr Rev (2008) 2.32
Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J Biol Chem (2001) 2.13
MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation. J Biol Chem (2005) 1.81
Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6. J Autoimmun (2012) 1.43
Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors. Arthritis Res Ther (2010) 1.24
The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases. Inflamm Allergy Drug Targets (2012) 1.21
Osteoporosis in inflammatory joint diseases. Osteoporos Int (2010) 1.21
Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts. Arthritis Res Ther (2006) 1.20
Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis. J Pathol (2007) 1.16
Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha. Ann Rheum Dis (2004) 1.14
Induction of chemokines and chemokine receptors CCR2b and CCR4 in authentic human osteoclasts differentiated with RANKL and osteoclast like cells differentiated by MCP-1 and RANTES. J Cell Biochem (2006) 1.09
A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis. Ann Rheum Dis (2010) 1.04
Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis. J Immunol (2005) 1.04
Synovial tissue heterogeneity and peripheral blood biomarkers. Curr Rheumatol Rep (2011) 1.02
From bone biology to clinical outcome: state of the art and future perspectives. Ann Rheum Dis (2010) 1.02
The proliferative human monocyte subpopulation contains osteoclast precursors. Arthritis Res Ther (2009) 1.01
MCP-1 expressed by osteoclasts stimulates osteoclastogenesis in an autocrine/paracrine manner. Biochem Biophys Res Commun (2009) 1.01
Fas (CD95)-related apoptosis and rheumatoid arthritis. Rheumatology (Oxford) (2005) 0.97
Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion. Arthritis Res Ther (2010) 0.95
Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos. Clin Exp Immunol (2006) 0.90
IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis. Inflammation (2013) 0.89
IL-18 inhibits TNF-alpha-induced osteoclastogenesis possibly via a T cell-independent mechanism in synergy with IL-12 in vivo. Calcif Tissue Int (2010) 0.83
Misconduct policies in high-impact biomedical journals. PLoS One (2012) 2.29
Completeness and changes in registered data and reporting bias of randomized controlled trials in ICMJE journals after trial registration policy. PLoS One (2011) 1.98
Cardiac myxoma the great imitators: comprehensive histopathological and molecular approach. Int J Cardiol (2012) 1.05
Regression of moral reasoning during medical education: combined design study to evaluate the effect of clinical study years. PLoS One (2011) 1.04
Bridging knowledge translation gap in health in developing countries: visibility, impact and publishing standards in journals from the Eastern Mediterranean. BMC Med Res Methodol (2012) 1.04
Why do you think you should be the author on this manuscript? Analysis of open-ended responses of authors in a general medical journal. BMC Med Res Methodol (2012) 1.00
How big is the 'next big thing'? Estimating the burden of non-communicable diseases in low- and middle-income countries. J Glob Health (2012) 0.97
Analysis of evidence supporting the Federation of Bosnia and Herzegovina reimbursement medicines lists: role of the WHO Essential Medicines List, Cochrane systematic reviews and technology assessment reports. Eur J Clin Pharmacol (2015) 0.96
Less work, less respect: authors' perceived importance of research contributions and their declared contributions to research articles. PLoS One (2011) 0.96
Medical students' decisions about authorship in disputable situations: intervention study. Sci Eng Ethics (2012) 0.90
Reducing mortality from childhood pneumonia and diarrhoea: The leading priority is also the greatest opportunity. J Glob Health (2013) 0.84
Vitamin D serum level, disease activity and functional ability in different rheumatic patients. Am J Med Sci (2015) 0.84
Methodological rigour and transparency of clinical practice guidelines developed by neurology professional societies in Croatia. PLoS One (2013) 0.84
No health research without education for research--experience from an integrated course in undergraduate medical curriculum. Med Teach (2013) 0.83
Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis. Int Orthop (2014) 0.82
Decreased level of sRAGE in the cerebrospinal fluid of multiple sclerosis patients at clinical onset. Neuroimmunomodulation (2014) 0.81
Teaching science throughout the six-year medical curriculum: two-year experience from the University of Split School of Medicine, Split, Croatia. Acta Med Acad (2014) 0.80
Reducing the burden of maternal and neonatal infections in low income settings. J Glob Health (2011) 0.80
Unrecognized ochronosis--a case report. Acta Clin Croat (2008) 0.80
Who would students ask for help in academic cheating? Cross-sectional study of medical students in Croatia. BMC Med Educ (2014) 0.79
Dermatoglyphics of digitopalmar complex in forty male patients affected by rheumatoid arthritis--quantitative analysis. Reumatizam (2009) 0.79
Osteoporosis in psoriatic arthritis: is there any? Wien Klin Wochenschr (2011) 0.79
[Therapeutic ultrasound in chronic low back pain treatment]. Reumatizam (2006) 0.78
Developing biobanks in developing countries. J Glob Health (2011) 0.78
Writing letters to patients as an educational tool for medical students. BMC Med Educ (2013) 0.77
Monthly or weekly bisphosphonate? Evaluation of satisfaction in patients with postmenopausal osteoporosis using OPSAT-Q questionnaire during the BOOSTER study in Croatia. Clin Rheumatol (2011) 0.77
Which clinical variables have the most significant correlation with quality of life evaluated by SF-36 survey in Croatian cohort of patient with ankylosing spondylitis and psoriatic arthritis? Rheumatol Int (2011) 0.77
Balancing investments in existing and emerging approaches to address global health priorities. J Glob Health (2012) 0.76
Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: a cross-sectional study. Rheumatol Int (2011) 0.76
[Proposal of Croatian Society for Rheumatology for anti-TNF-alpha therapy in adult patients with spondyloarthritides]. Reumatizam (2007) 0.75
Osteoblastogenesis from synovial fluid-derived cells is related to the type and severity of juvenile idiopathic arthritis. Arthritis Res Ther (2012) 0.75
Evidence base for mentoring women in academic medicine. J Grad Med Educ (2012) 0.75
Good season ahead. Croat Med J (2011) 0.75
Echoes of the Sarajevo Declaration on integrity and visibility of scholarly publications. Croat Med J (2017) 0.75
Correction: Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. PLoS Med (2016) 0.75
Advanced Clinical and Radiological Features of Ankylosing Spondylitis: Relation to Gender, Onset of First Symptoms and Disease Duration. Coll Antropol (2015) 0.75
Dermatoglyphics in psoriatic symmetrical polyarthritis in fifty women--quantitative analysis. Reumatizam (2010) 0.75
Cochrane Rehabilitation: Organization and Functioning. Am J Phys Med Rehabil (2017) 0.75
[Therapeutic exercise for patients with chronic low-back pain]. Lijec Vjesn (2015) 0.75
[A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement]. Z Evid Fortbild Qual Gesundhwes (2017) 0.75
Bone morphogenetic proteins regulate differentiation of human promyelocytic leukemia cells. Leuk Res (2013) 0.75
A contribution to genetic etiology of complex regional pain syndrome type I (algodystropy syndrome) based on quantitative analysis of digitopalmar dermatoglyphics in sixty men. Reumatizam (2005) 0.75
[Comparison of standard and acupuncture methods of transcutaneous electric nerve stimulation (TENS) in patients with rheumatoid arthritis]. Reumatizam (2003) 0.75
[Treatment of chronic pain--use of transdermal fentanyl (Durogesic TTS)]. Reumatizam (2002) 0.75
Quantitative analysis of digitopalmar dermatoglyphics in fifty male psoriatic spondylitis patients. Reumatizam (2012) 0.75